Future research should focus on selective inhibition or activation of specific subtypes, combined with techniques such as single-cell sequencing and metabolomics, to clarify their tissue-specific effects
To test whether Gipr antagonism affects energy metabolism via a similar mechanism, we treated DIO Vgat-Cre + Gipr wt/wt (WT) and Vgat-Cre + Gipr flx/flx ( Vgat-Gipr knockout (KO)) mice for 24 days with either vehicle, a long-acting GLP-1R agonist (acyl-GLP-1, 10 nmol kg 1 ) 13,14,15 or the combination of acyl-GLP-1 (10 nmol kg 1 ) and a validated long-acting (acylated) peptide GIPR antagonist (1,500 nmol kg 1 ) 22
Using degraded semaglutide does not just mean reduced potency
Among all semaglutide-based medications, Wegovy stands out as the most effective weight loss drug due to its FDA approval specifically for long-term treatment of obesity or overweight in adults and adolescents with weight-related health conditions
Increasing focus on preventive healthcare and long-term weight management is also driving physician confidence in GLP-1 therapy use